<p>Number of patients and the number of all ordered doses not administered, by total of ordered doses not given during the patient visit.</p
<p>Proportion of patients according to the number of drugs of the respective QT-category of risk-cla...
<p>Number of patients who had the follow up sample in each two-month period of time.</p
Actual numbers of patients who had ingested different types of organophosphates.</p
Number (percentage) of patients who received at least one of the drugs in the given groups.</p
<p>Number of facilities and number of patients by ownership and level of care.</p
<p>The number of patients by the number of events for each primary outcome, by the treatment group.<...
<p>Number of unique drug regimens per 100 subjects taking a given number of medications.</p
Number of vaccine doses administered and median interval of TBE occurrence in any patient with TBE w...
<p>Number of ADRs per patient with ≥ one ADR according to origin of prescription.</p
<p>Numbers of medications initiated for each indication and discontinued within observation period b...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
<p>Number of test results showing impairment and no impairment for each AH by dose.</p
<p>Number of measurements (defined as either left or right MCA measurements) available per patient.<...
<p>Number of patients who required oxygen therapy by disease group and individual diagnosis.</p
Number of serum specimens, number of contributing patients, and age of patients by specimen type.</p
<p>Proportion of patients according to the number of drugs of the respective QT-category of risk-cla...
<p>Number of patients who had the follow up sample in each two-month period of time.</p
Actual numbers of patients who had ingested different types of organophosphates.</p
Number (percentage) of patients who received at least one of the drugs in the given groups.</p
<p>Number of facilities and number of patients by ownership and level of care.</p
<p>The number of patients by the number of events for each primary outcome, by the treatment group.<...
<p>Number of unique drug regimens per 100 subjects taking a given number of medications.</p
Number of vaccine doses administered and median interval of TBE occurrence in any patient with TBE w...
<p>Number of ADRs per patient with ≥ one ADR according to origin of prescription.</p
<p>Numbers of medications initiated for each indication and discontinued within observation period b...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
<p>Number of test results showing impairment and no impairment for each AH by dose.</p
<p>Number of measurements (defined as either left or right MCA measurements) available per patient.<...
<p>Number of patients who required oxygen therapy by disease group and individual diagnosis.</p
Number of serum specimens, number of contributing patients, and age of patients by specimen type.</p
<p>Proportion of patients according to the number of drugs of the respective QT-category of risk-cla...
<p>Number of patients who had the follow up sample in each two-month period of time.</p
Actual numbers of patients who had ingested different types of organophosphates.</p